Who invested in New Amsterdam Pharma

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$453Mraised across 1 round since 2024, from 1 source

Latest round: Round, $453MDec 2024
Investors: 4

See who backed them

The rounds

Dec 2024
Round$453M
Source recorded

Everyone who backed them

RA Capital ManagementPrivate equity1round

Janus Henderson InvestorsPrivate equity1round

Forbion Capital PartnersPrivate equity1round

Bain Capital Life SciencesPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list New Amsterdam Pharma as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Frazier Life SciencesVC firmPer its own site

JVC Investment PartnersVC firmPer its own site

Quick answers about New Amsterdam Pharma

Who invested in New Amsterdam Pharma?

New Amsterdam Pharma's investors include RA Capital Management, Janus Henderson Investors, Forbion Capital Partners and Bain Capital Life Sciences.

How much has New Amsterdam Pharma raised?

New Amsterdam Pharma has raised $453M across 1 round since 2024.

When did New Amsterdam Pharma last raise?

New Amsterdam Pharma's most recent round was an Undisclosed round of $453M in Dec 2024.

What was New Amsterdam Pharma's biggest round?

Its most recent round, $453M in Dec 2024, is also its largest on record.

Who backed New Amsterdam Pharma first?

New Amsterdam Pharma's first round on record, in Dec 2024, was backed by RA Capital Management, Janus Henderson Investors and Forbion Capital Partners and 1 others.